574 POSTER Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway
K. Thress, T. MacIntyre, H. Wang, Z.Y. Liu, E. Hoffmann, T. Wang, D. Whitston, J.L. Brown, K. Webster, C. OmerVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72508-4
File:
PDF, 59 KB
english, 2008